Compare NA & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NA | HYFT |
|---|---|---|
| Founded | 2019 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5M | 80.8M |
| IPO Year | 2022 | 2017 |
| Metric | NA | HYFT |
|---|---|---|
| Price | $3.11 | $1.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 149.1K | ★ 313.2K |
| Earning Date | 08-15-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,369,693.00 | ★ $19,019,110.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $51.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 49.46 |
| 52 Week Low | $2.75 | $0.27 |
| 52 Week High | $31.48 | $3.25 |
| Indicator | NA | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 37.48 | N/A |
| Support Level | $2.98 | N/A |
| Resistance Level | $3.46 | N/A |
| Average True Range (ATR) | 0.16 | 0.00 |
| MACD | 0.06 | 0.00 |
| Stochastic Oscillator | 26.32 | 0.00 |
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.